Outlook Therapeutics

$Outlook Therapeutics(OTLK)$ 貌似老日跟老欧批了，如果月底批了貌似潜力还挺大？

#药闻简讯# $Outlook Therapeutics(OTLK)$ 宣布LYTENAVA（贝伐珠单抗γ）在德国和英国商业上市，用于治疗湿性年龄相关性黄斑变性

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000947871-25-000571  Size: 10 KB 网页链接

$Outlook Therapeutics(OTLK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-003535  Act: 34  Size: 13 KB 网页链接

$Outlook Therapeutics(OTLK)$ 8-K Current report, item 8.01 Accession Number: 0001104659-25-055521  Act: 34  Size: 186 KB 网页链接

$Outlook Therapeutics(OTLK)$
NORSE EIGHT第8周主要终点未达到预设的非劣效性标准，批的概率小

$Outlook Therapeutics(OTLK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-25-078622  Act: 34  Size: 337 KB 网页链接

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-019586  Size: 5 KB 网页链接

$Outlook Therapeutics(OTLK)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-25-019585  Size: 3 KB 网页链接

$Outlook Therapeutics(OTLK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-25-011588  Act: 34  Size: 10 MB 网页链接

$Outlook Therapeutics(OTLK)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000947871-25-000572  Act: 34  Size: 20 KB 网页链接

$Outlook Therapeutics(OTLK)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-003290  Act: 34  Size: 16 KB 网页链接

$Outlook Therapeutics(OTLK)$ 重新提交后，2025年8月27日（PDUFA）

$Outlook Therapeutics(OTLK)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001104659-25-064755  Act: 34  Size: 306 KB 网页链接

$Outlook Therapeutics(OTLK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001214659-25-012269  Act: 34  Size: 15 KB 网页链接